Evidence map›Paper›PMID 36676895›Full record

ArticleMembranes2023

Defect Detection Sensitivity of Bubble-Point-Type Tests for Sterilizing-Grade Membrane Cartridge Filters.

Sal Giglia, Anand Alembath, Joseph Hersey

Abstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sal GigliaEMD Millipore Corporation, an Affiliate of Merck, Bedford, MA 01730, USA.ORCID 0000-0002-1191-0136
Anand AlembathEMD Millipore Corporation, an Affiliate of Merck, Bedford, MA 01730, USA.ORCID 0000-0003-1722-2702
Joseph HerseyEMD Millipore Corporation, an Affiliate of Merck, Bedford, MA 01730, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bubble point tests are widely used for assessing the integrity of sterilizing-grade membrane cartridge filters. While many authors have considered the limitations of bubble point tests as applied to cartridge filters, the level of bacterial retention assurance provided by this test as conducted with automated integrity testers (AITs) has not, until now, been quantified. Contrary to the notion that filter leaks result in a depressed bubble point, it was shown that the bubble point as reported by AITs was insensitive to defect size up until the point where the AIT either determined a gross leak failure or was not able to return a valid result. For the three AITs used in this study, the minimum laser hole defect diameter in 10-inch (25.4 cm) sterilizing-grade cartridge filters that resulted in a failing bubble point test was between about 30 and 60 µm, depending on the filter type and test conditions. These defect sizes were associated with bacterial log reduction values in the 4.0 to 4.5 range. This study supports the generally recommended practice of pairing the bubble point test (which does confirm proper pore size rating) with a complementary gas-liquid diffusion test (better suited for detecting defects) to achieve a more comprehensive assessment of filter integrity.

Indexed as

bacterial retentionbubble pointfilter defectintegrity teststerilizing filter

Identifiers

PMID36676895
PMCPMC9865406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.